Our best-in-class products channel symbioses among microbes.
Our portfolio of microbe-based products addresses high unmet needs across human health.
Consumer Skin Health
Our portfolio of skin health ingredients spans solutions for malodor, barrier strength, acne, dandruff, and beyond.
Learn More About CB-0XX
Atopic Dermatitis
ENS-002 pacifies S. aureus virulence as a candidate therapeutic for atopic dermatitis.
Learn More About ENS-002
Recurrent Vaginal Yeast Infection
ENS-003 inhibits C. albicans virulence—seeding Concerto’s understanding of how the vaginal microbiome maintains a healthy balance.
Learn More About ENS-003
We welcome partners to accelerate advancement of our existing products or co-discover something new.
Partner with us to leverage 50+ million proprietary datapoints across skin and vaginal health—further enhanced by an AI model of microbial ecology—for breakthrough discovery.
40M+ measurements of skin microbial ecology form the foundation for product discovery.
Concerto has learned how critical microbes implicated in skin health (C. acnes, S. epidermidis, etc.) are influenced by combinations of skin microbes. This dataset serves as a goldmine for hit generation, fueling Concerto’s ingredient portfolio and strengthening a foundation for partnering around novel dermatology assets.
Companies are stronger together.
Concerto’s partners gain access to top-performing, differentiated ingredients that add value to their portfolios. Inquire about the list of ingredient candidates we have waiting in the wings. Or propose a new product concept that leverages Concerto’s 50+ million data points across skin and vaginal health.
Harness microbial ecology with Concerto to develop new, transformative products.
Partner With UsMicrobes, like humans, are stronger together than they ever could be alone.
750 Main Street
Cambridge, MA 02139